Cieślik Paulina, Borska Magdalena, Wierońska Joanna Monika
Department of Neurobiology, Maj Institute of Pharmacology Polish Academy of Sciences, Smętna 12, 31-343 Kraków, Poland.
Brain Sci. 2023 Feb 27;13(3):410. doi: 10.3390/brainsci13030410.
Learning and memory deficits accompany numerous brain dysfunctions, including schizophrenia and Alzheimer's disease (AD), and many studies point to the role of nitric oxide (NO) in these processes. The present investigations constitute the follow-up of our previous research, in which we investigated the activity of NO releasers and a selective inhibitor of neuronal NO synthase (nNOS) to prevent short-term memory deficits in novel object recognition and T-maze. Here, the ability of the compounds to prevent the induction of long-term memory deficits by MK-801 or scopolamine administration was investigated. The Morris Water Maze test, a reliable and valid test of spatial learning and memory, was used, in which escape latency in the acquisition phase and nine different parameters in the retention phase were measured. A fast NO releaser (spermine NONOate), a slow NO releaser (DETA NONOate), and a nNOS inhibitor, N(ω)-propyl-L-arginine (NPLA), were used. The compounds were administered i.p. at a dose range of 0.05-0.5 mg/kg. All compounds prevented learning deficits in the acquisition phase and reversed reference memory deficits in the retention phase of the scopolamine-treated mice. Spermine NONOate was the least effective. In contrast, the drugs poorly antagonised MK-801-induced deficits, and only the administration of DETA NONOate induced some improvements in the retention trial.
学习和记忆缺陷伴随着多种脑功能障碍,包括精神分裂症和阿尔茨海默病(AD),许多研究指出一氧化氮(NO)在这些过程中的作用。本研究是我们之前研究的后续,在之前的研究中,我们研究了NO释放剂和神经元型一氧化氮合酶(nNOS)选择性抑制剂预防新物体识别和T迷宫中短期记忆缺陷的活性。在此,研究了这些化合物预防MK-801或东莨菪碱诱导长期记忆缺陷的能力。使用了莫里斯水迷宫试验,这是一种可靠且有效的空间学习和记忆试验,测量了获取阶段的逃避潜伏期和保持阶段的九个不同参数。使用了一种快速NO释放剂(精胺NONOate)、一种缓慢NO释放剂(DETA NONOate)和一种nNOS抑制剂N(ω)-丙基-L-精氨酸(NPLA)。化合物腹腔注射给药,剂量范围为0.05-0.5mg/kg。所有化合物均预防了东莨菪碱处理小鼠获取阶段的学习缺陷,并逆转了保持阶段的参考记忆缺陷。精胺NONOate效果最差。相比之下,这些药物对MK-801诱导的缺陷拮抗作用较差,只有DETA NONOate给药在保持试验中诱导了一些改善。